William W Walker, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2000 East Greenville St, Suite 1100, Anderson, SC 29621 Phone: 864-225-5667 Fax: 864-716-6746 |
Charles Armistead Thompson, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1214 N Fant St Ste B, Anderson, SC 29621 Phone: 864-540-8025 Fax: 864-540-8027 |
News Archive
Glenmark Generics Inc. USA, the subsidiary of Glenmark Generics Limited, has been granted final approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca.
During each cell division, more than 3.3 billion base pairs of genomic DNA have to be duplicated and segregated accurately to daughter cells. But what happens when the DNA template is damaged in such a way that the replication machinery gets stuck? To answer this question, scientists in the team of Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried near Munich, with colleagues in Copenhagen and at Harvard, have analyzed how the protein composition of the DNA replication machinery changes upon encountering damaged DNA.
Prostate cancer is the most commonly diagnosed malignancy and second leading cause of cancer-related deaths among men in the U.S. The challenge with prostate cancer is that the standard treatment methods in the advanced stage of the disease lose effectiveness after about one to two years, leading to recurrence and, ultimately, death. A University of Houston researcher and his team are working to change that.
Angelina Jolie received widespread media attention in 2013 when she told the public that she'd tested positive for BRCA1, a gene associated with an increased risk of breast and ovarian cancers, and subsequently had a double mastectomy. Now research shows that this publicity did influence some women's intentions to seek out similar genetic testing.
The Functional Materials Group at the School of Physical Sciences, University of Kent, has received additional funding from the Engineering and Physical Sciences Research Council (EPSRC) to continue its research on new forms of bioactive glass.
› Verified 9 days ago